PRKN and Parkinson disease: Accordingly, biallelic PRKN mutation carriers had a significantly earlier age of symptom onset compared to mutation-negative PD (28.3 ± 8.7 vs 52.3 ± 15.0 years; r = 0.34, P = 5.49e−13, Mann–Whitney U test).